Cerebral blood flow in patients with cerebrovascular disorders: study with pentoxifylline.

Twenty outpatients (8 women and 12 men; age range 52-66 years) with mild to moderate degree of cerebrovascular disorders and arteriosclerotic dementia, were randomly assigned to either control or pentoxifylline group (400 mg X 3/day/4 weeks p.o.). Measurements of cerebral blood flow (133Xe) show in the right hemisphere of the treated group a significant… CONTINUE READING